Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management.
about
Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease (COPD)ncRNA-regulated immune response and its role in inflammatory lung diseasesMetabolic Disorder in Chronic Obstructive Pulmonary Disease (COPD) Patients: Towards a Personalized Approach Using Marine Drug Derivatives.Hyperlipidemia in COPD is associated with decreased incidence of pneumonia and mortality: a nationwide health insurance data-based retrospective cohort studyPrediction of Long-Term Benefits of Inhaled Steroids by Phenotypic Markers in Moderate-to-Severe COPD: A Randomized Controlled TrialProbing Cellular and Molecular Mechanisms of Cigarette Smoke-Induced Immune Response in the Progression of Chronic Obstructive Pulmonary Disease Using Multiscale Network Modeling.Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME Trial.An Epidemiological Overview of Chronic Obstructive Pulmonary Disease: What Can Real-Life Data Tell Us about Disease Management?Mental health, serum biomarkers and survival in severe COPD: a pilot study.Combining systems pharmacology, transcriptomics, proteomics, and metabolomics to dissect the therapeutic mechanism of Chinese herbal Bufei Jianpi formula for application to COPD.Determinants for changing the treatment of COPD: a regression analysis from a clinical audit.Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD.The Healthy Infant Nasal Transcriptome: A Benchmark StudyEffectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts.Rising total costs and mortality rates associated with admissions due to COPD exacerbations.Chronic Obstructive Pulmonary Disease, Neutrophils and Bacterial Infection: A Complex Web Involving IL-17 and IL-22 UnravelsEmerging pharmaceutical therapies for COPD.Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD.Use of inhaled corticosteroids in COPD: improving efficacy.Treatment options for moderate-to-very severe chronic obstructive pulmonary disease.Bringing Stability to the Chronic Obstructive Pulmonary Disease Patient: Clinical and Pharmacological Considerations for Frequent Exacerbators.Can we predict the prognosis of COPD with a routine blood test?The place of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease: a narrative review.Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease.Phenotyping Before Starting Treatment in COPD?Lower diffusing capacity with chronic bronchitis predicts higher risk of acute exacerbation in chronic obstructive lung disease.Prevalence of blood eosinophilia in hospitalized patients with acute exacerbation of COPD.Effect of Fluticasone Furoate and Vilanterol on Exacerbations of Chronic Obstructive Pulmonary Disease in Patients with Moderate Airflow Obstruction.Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.The need to increase awareness of the risk factors of COPD.Inhaled Steroids and Active Smoking Drive Chronic Obstructive Pulmonary Disease Symptoms and Biomarkers to a Greater Degree Than Airflow Limitation.Poly(ADP-Ribose)Polymerase-1 in Lung Inflammatory Disorders: A Review.The EASI model: A first integrative computational approximation to the natural history of COPDChronic Respiratory Symptoms with Normal Spirometry. A Reliable Clinical Entity?Triple Therapy for Chronic Obstructive Pulmonary Disease Management. Are Our Expectations Fulfilled?Natural history of COPD: gaps and opportunities.Thin-section computed tomography-determined usual interstitial pneumonia pattern affects the decision-making process for resection in newly diagnosed lung cancer patients: a retrospective study.Recent insights into human bronchial proteomics - how are we progressing and what is next?Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.Chronic obstructive pulmonary disease: More than meets the eye.
P2860
Q24186189-2ED929FA-BCFA-41E5-B68A-F584E6742CF8Q28082698-CA6C8521-DAE9-42B9-AE8C-190522EFA93CQ30235126-1DF4299D-48FE-455D-9938-60AD82BCAD4EQ31106367-5E659A02-18EE-41CB-A0B2-4127999D9994Q35867300-B9AF4C88-337D-40A7-8F2F-62058E0AE578Q36145085-FE308F7A-CED8-4354-9FE7-2CBBC7DECE52Q36302882-CDB4557A-7D33-4C25-913C-CDFEC7D34FBAQ36312044-885FF563-A988-489B-8F3B-ECAFA34189E8Q36476007-C56A4FD0-6BAF-46EF-8587-69657FA11924Q36710084-5D11F7D2-BB85-4711-87C4-8C373F8E6C26Q36981197-F2FBD2A2-46AB-4144-858D-E3A390700D85Q37074953-1E2D7B44-A714-4492-9C07-0A1BA163052CQ37277996-9707E4FF-ABF6-46D9-BB37-3FB21D3051D1Q37283465-31556309-0531-4B7F-AF53-7829250AF4D2Q37414845-824BCE14-15EC-41A4-8BA3-CEAEB8BD2F3BQ38255466-AECC1E77-BA59-4F9D-83F7-8521E6DCAC93Q38645203-8F8538DB-AF76-4E9A-8166-E84ECB578AE0Q38685218-1930CE07-0713-4E7D-96FB-3CB02B2BCB95Q38726082-B15F619F-6FF3-4F0C-9D9C-5F8E56D78619Q38740756-B556151D-AF28-4F99-BEEF-68F43C0D77A0Q38751226-812AD9B4-5B0E-4A1A-9035-1ED24FE57592Q38752544-3E0E981C-EB25-42D9-BF35-3C926D5949F7Q38827675-B838AB3E-63B5-4113-80C2-8365CBAEE7D2Q38923185-B8973227-3380-431F-85EC-6C6E1EE10CC9Q39226768-7C86B0EE-E708-44CC-8F45-0532645D57B2Q39689013-F9324B0F-7417-4B70-863F-BE16A991803DQ40176175-1C29F43C-C679-4CE5-BF29-D309E44AB41DQ40494559-5C57F9DE-AF8C-4E6B-958F-158618CA472FQ40598255-1B4C6EB9-2876-4BBB-B2FF-4B5FA34D149CQ40772698-F7F656A9-BAAD-4A03-B928-4B95E54A0E72Q41665001-E761056D-BBD1-4D3C-A9C1-3DC3D904A252Q41820940-8482DBEE-83DE-44AD-AA69-B3F61F6E251DQ42696087-D8C1D511-B2CE-4F8D-9053-5DE1AA5F7086Q46167856-061FBC0E-53D9-4BFD-B999-86F22F780AEAQ46513467-71090E31-942F-4F15-81E3-18712F543756Q47120721-AFAD42AC-DC2C-4221-9CDF-569AE38A0DF1Q47204595-2A1D6FB7-7D7D-4956-A252-76ED445BB731Q47271963-3EF71E41-898F-4EBD-91BF-42B26D67C9ABQ47547470-0624A1E2-0097-48FA-95C1-34DA1834B966Q47641727-C9AA5706-7524-48A7-AF7A-C719FD9670BB
P2860
Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Current concepts in targeting ...... wards personalised management.
@en
type
label
Current concepts in targeting ...... wards personalised management.
@en
prefLabel
Current concepts in targeting ...... wards personalised management.
@en
P2093
P2860
P1433
P1476
Current concepts in targeting ...... owards personalised management
@en
P2093
Alvar Agusti
Dave Singh
Fernando J Martinez
Prescott G Woodruff
P2860
P304
P356
10.1016/S0140-6736(15)60693-6
P407
P577
2015-05-01T00:00:00Z